Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,1213,140 of 20,252 grants

Active RESEARCH CENTERS
Prevention of MGUS Progression to MM by Modulating the Bone Marrow Microenvironment
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2023 – 2027

PROJECT SUMMARY The long-term objective of this work is to determine the functional role of the bone marrow microenvironment in regulating the plasma cell growth of monoclonal gamm...

Active RESEARCH CENTERS
Prevent IgM MGUS Progression by Targeting the Driver Mutation
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2023 – 2027

Prevent IgM MGUS Progression by Targeting the Driver Mutation Project Summary Patients with monoclonal gammopathy of undetermined significance of the IgM class (IgM MGUS) are at in...

Active RESEARCH CENTERS
Bioinformatics Core
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2023 – 2027

Bioinformatics Core Project Summary All forms of the incurable plasma cell malignancies, multiple myeloma (MM), and Waldenstrom’s macroglobulinemia (WM) emerge from a precursor con...

Active TRAINING, INSTITUTIONAL
Epigenetics, Metabolism and Cancer
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2023 – 2028

Project Summary It is now well accepted that epigenetic and metabolic factors are major drivers of tumorigenesis and the link between the two pathways will be central in cancer the...

$3.53M
USD
Active OTHER RESEARCH-RELATED
Determinants of resistance to engineered T-cell therapies targeting CD19 in lymphoma
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2023 – 2028

Project Summary/Abstract The outcomes for patients with large B-cell lymphoma (LBCL) that are relapsed or refractory to frontline therapy remain quite poor. While anti-CD19 chimeri...

$1.88M
USD
Active NON-SBIR/STTR RPGS
Metabolism of cancer chemotherapeutics by the human gut microbiome
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2023 – 2028

PROJECT SUMMARY Rigorous data from our lab and others indicate that the gut microbiome may an underappreciated contributor to inter-individual variations in cancer drug efficacy an...

$5.74M
USD
Active TRAINING, INDIVIDUAL
Alternate splicing as a source of shared neoantigens in a non-small cell lung cancer
NATIONAL CANCER INSTITUTE University of Connecticut Sch of Med/Dnt United States 2023 – 2027

PROJECT SUMMARY/ABSTRACT Non-small cell lung cancer (NSCLC) is the leading cause of cancer mortality in the United States. Immune checkpoint inhibitors (ICIs) like anti-PD-1 have i...

$539.7K
USD
Active NON-SBIR/STTR RPGS
Transcriptional Regulation of Dormancy and Emergence in Breast Cancer
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2023 – 2028

Breast cancer ranks second among cancer deaths in women in the United States. Breast cancer-related mortality primarily results from metastatic growth of disseminated cells. While...

$4M
USD
Active TRAINING, INDIVIDUAL
Role of hypoxia in CD8+ T cell exclusion and suppression in pancreatic cancer
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2023 – 2027

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDAC) is a deadly malignancy characterized by poor response to all existing therapies. Although immunotherapy has shown great prom...

$416.6K
USD
Active OTHER RESEARCH-RELATED
Medical Students Summer in Oncology at Anderson Research (Med Students SOAR) program
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

PROJECT SUMMARY The goal of the Medical Students Summer in Oncology at Anderson Research (Med Students SOAR) program is to provide 25 talented first-year medical students per year...

$3.23M
USD
Completed NON-SBIR/STTR RPGS
Development of Mouse and Humanized Models to Study Sex Disparities in Tumor Progression and Treatment of NSCLC
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2023 – 2025

Project Summary According to the American Cancer Society, lung cancer is the second most commonly diagnosed cancer in men and women. Outside of the sex-specific cancers, lung cance...

$1.72M
USD
Active NON-SBIR/STTR RPGS
Development of Magnetic Resonance Fingerprinting (MRF) to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2023 – 2028

Abstract In women, breast cancer is the most commonly diagnosed cancer and leading cause of cancer related deaths worldwide, with approximately 2.3 million new cases and 685,000 de...

$5.37M
USD
Active NON-SBIR/STTR RPGS
A High-Throughput Screening Platform to Discover RNA Methylation Inhibitors
NATIONAL CANCER INSTITUTE Duke University United States 2023 – 2026

Summary Cellular mRNAs are susceptible to a variety of chemical modifications that play important roles in regulating gene expression and cellular function. The most abundant inter...

$3.81M
USD
Active NON-SBIR/STTR RPGS
Refer 2 Quit: Proactive Promotion of Tobacco Use Treatment for Underserved Household Members Who Smoke through Pediatric Primary Care
NATIONAL CANCER INSTITUTE Children'S Hosp of Philadelphia United States 2023 – 2028

Project Summary/Abstract Racial and ethnic minority groups and those from low socioeconomic groups suffer disproportionately from the effects of tobacco marketing, have less access...

$7.08M
USD
Active OTHER RESEARCH-RELATED
Design and implementation of a social cognitive theory-based medication adherence coaching intervention
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2023 – 2028

ABSTRACTDr. Benyam Muluneh’s long-term career goal is to become a leading clinician-researcher in oncology by leveraging health behavior theories and implementation science methods...

$1.94M
USD
Active NON-SBIR/STTR RPGS
Social Determinants of Health as Transducers of Cellular Aging: A New Multi-level Paradigm to Reduce Survivorship Disparities at the Intersection of Cancer and Aging
NATIONAL CANCER INSTITUTE Georgetown University United States 2023 – 2030

By 2030, three-quarters of the 22 million US cancer survivors will be 65 and older and the number of older Hispanic and Black survivors will have grown three times faster than Whit...

$8.88M
USD
Active OTHER RESEARCH-RELATED
The role of stem-like CD8 T-cells in the abscopal response
NATIONAL CANCER INSTITUTE Emory University United States 2023 – 2028

PROJECT SUMMARY Prognosis is poor for patients diagnosed with locally advanced melanoma. Survival outcomes are improved with checkpoint blockade in the neoadjuvant, adjuvant and un...

$2.42M
USD
Completed RESEARCH CENTERS
Administrative Core
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2024

PROJECT SUMMARY (ADMINISTRATIVE CORE) The Administrative Core provides essential support to the MD Anderson Cancer Center and Temple/Fox Chase Cancer Center Leukemia SPORE PIs and...

Completed RESEARCH CENTERS
Core 3: Biostatistics, Data Management, and Bioinformatics
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2024

Project Summary The major objective of the Biostatistics and Bioinformatics Core (Core 3) is to provide centralized biostatistics, bioinformatics, and database support for all Proj...

Completed RESEARCH CENTERS
Epigenetic and Genetic Vulnerabilities in Synovial Sarcoma
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2024

ABSTRACT RP-4 focuses on synovial sarcoma, an aggressive pediatric/young adult sarcoma driven by the SS18-SSX fusion oncogene. SS18-SSX has emerged as a multi-faceted disruptor of...